SGB-3908

· Suzhou Sanegene Bio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SGB-3908, covering 2026-02-10 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of SGB-3908 in Healthy Subjects and Mildly Hypertensive Subjects [Phase 1]